Using a smartphone app for rehabilitation in patients with chronic respiratory or cardiovascular diseases
Efficacy of Smartphone Application Based Rehabilitations in Patients With Chronic Respiratory or Cardiovascular Disease
This study is testing a new smartphone app to see if it can help people with chronic respiratory or heart diseases improve their exercise ability and overall quality of life over 12 weeks.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 162 (estimated) |
| Ages | 20 Years to 80 Years |
| Sex | All |
| Sponsor | Asan Medical Center Academic / other |
| Locations | 1 site (Seoul) |
| Trial ID | NCT05610358 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of a newly developed smartphone application designed for rehabilitation in patients suffering from chronic respiratory or cardiovascular diseases. Participants will engage in a 12-week program utilizing the app, which focuses on improving exercise capacity, reducing dyspnea symptoms, enhancing muscle strength, and overall quality of life. The study will assess the outcomes of these interventions to determine their efficacy in a population that may have limited access to traditional rehabilitation methods.
Who should consider this trial
Good fit: Ideal candidates include adults aged 20 to 80 with chronic respiratory or cardiovascular diseases who experience dyspnea symptoms.
Not a fit: Patients with a recent history of acute exacerbation or those unable to comply with the rehabilitation program may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide an accessible and effective rehabilitation option for patients with chronic respiratory or cardiovascular diseases.
How similar studies have performed: While the use of smartphone applications for rehabilitation is a growing field, this specific approach is novel and has not been extensively tested in similar populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Dyspnea symptom \>= mMRC 1 or NYHA II * adults between 20 years and 80 or years * Chronic respiratory disease * FEV1/FVC \< 0.7 or FEV1\< 0.8 of predicted value in pulmonary function test * bronchiectasis in more than one lobe on chest computed tomography * FVC or DLCO \< 0.8 of predicted value in pulmonary function test * Chronic cardiovascular disease * Reperfusion Therapy for angina pectoris or myocardial infarction * Heart failure with reduced ejection fraction (LVEF \< 50%) Exclusion Criteria: * history of acute exacerbation within 4 weeks * unable to comply rehabilitation program * not suitable for study on decision by duty physician * no consent
Where this trial is running
Seoul
- Asan Medical Center — Seoul, Korea, Republic of (Recruiting)
Study contacts
- Study coordinator: Sei Won Lee, MD PhD
- Email: iseiwon@gmail.com
- Phone: 82-2-3010-3990
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.